[MeMed in PR Newswire] MeMed Completes Trilogy of Clinical Studies with More Than 2,000 Patients Validating First Ever Blood Test to Accurately Distinguish Between Bacterial and Viral Infections

MeMed today announced positive results from a large, external double-blinded PATHFINDER study that met its primary endpoint, independently confirming that MeMed’s novel blood test, ImmunoXpert™, accurately distinguishes between bacterial and viral infections in children.

Read more on PR Newswire here.